DEXILANT

This brand name is authorized in United States. It is also authorized in Brazil, Canada, Ecuador, Germany, Hong Kong SAR China, Israel, Lithuania, Poland, Singapore.

Active ingredients

The drug DEXILANT contains one active pharmaceutical ingredient (API):

1	Dexlansoprazole UNII UYE4T5I70X - DEXLANSOPRAZOLE
	Dexlansoprazole belongs to a class of antisecretory compounds, the substituted benzimidazoles, that suppress gastric acid secretion by specific inhibition of the (H+, K+)-ATPase at the secretory surface of the gastric parietal cell.
	Read more about Dexlansoprazole

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
DEXILANT Delayed-release capsules	MPI, US: SPL/PLR	FDA, National Drug Code (US)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
A02BC06	Dexlansoprazole	A Alimentary tract and metabolism → A02 Drugs for acid related disorders → A02B DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD) → A02BC Proton pump inhibitors
Discover more medicines within A02BC06

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
BR	Câmara de Regulação do Mercado de Medicamentos	501112070019102, 501112070019202, 501112070019302, 501112070019402, 501112070019502, 501112070019602, 501112070019702, 501112070019802
CA	Health Products and Food Branch	02354950, 02354969
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	10358180, 10358197, 10358205, 10358211
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	42-MEE-0114, 74-MEE-0214
HK	Department of Health Drug Office	61372, 61373
IL	מִשְׂרַד הַבְּרִיאוּת	7911, 7912
LT	Valstybinė vaistų kontrolės tarnyba	1065692, 1065693, 1071852, 1071853, 1075642, 1075643, 1083392, 1083393, 1083394, 1083395, 1084821, 1084822, 1088119, 1088120, 1089400, 1089401, 1089402, 1089403, 1089643, 1089644
PL	Rejestru Produktów Leczniczych	100306888, 100306894
SG	Health Sciences Authority	14485P, 14486P
US	FDA, National Drug Code	50090-4374, 55154-5154, 64764-171, 64764-175